Fewer people claimed non-dom tax status in UK ahead of Government crackdown
There were about 73,700 people claiming non-domiciled tax status in the year ending in April last year, according to estimates from HM Revenue & Customs (HMRC).
This was 400 fewer than the 2022-23 tax year, or a dip of about 0.5%.
The number of non-doms, according to self-assessment tax returns, stood 3,900 below that in the tax year ending 2020.
It indicates a slowdown in the number of people claiming the tax status following a post-pandemic resurgence.
Non-domiciled means UK residents whose permanent home, or their 'domicile' for tax purposes, is outside the UK.
The regime meant that so-called non-doms paid tax in the UK only on income generated in the UK – meaning any income earned overseas was exempt from British taxation.
However, the Labour Government abolished the non-dom tax status in April following backlash that wealthy residents could enjoy the benefits of living in the UK without paying as much tax.
Previous chancellor Jeremy Hunt estimated that scrapping the regime would raise about £2.7 billion for the Treasury by 2028-29.
Recent data showed the UK saw the biggest fall in billionaires on record amid the Government non-dom clampdown.
The Sunday Times Rich List said there were fewer of the world's 'super rich' coming to live in Britain.
HMRC's data published on Thursday showed that some £9 billion was raised from non-doms paying income tax, capital gains tax and national insurance last year.
This was a £107 million increase on the prior year, despite the dip in the number of individuals.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
Merck (MRK) as a Reliable Dividend Player in the Dogs of the Dow Lineup
Merck & Co., Inc. (NYSE:MRK) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A close-up of a person's hand holding a bottle of pharmaceuticals. Merck & Co., Inc. (NYSE:MRK) has faced stock pressure due to its reliance on Keytruda but is diversifying. On July 9, Merck announced it would acquire UK biotech Verona Pharma for $10 billion, adding Ohtuvayre, a promising COPD treatment approved last year, to its portfolio. Ohtuvayre has had a strong launch and is being studied for more uses. Some analysts predict its sales could reach $4 billion, potentially making it another blockbuster for Merck. In its first quarter earnings, Merck & Co., Inc. (NYSE:MRK) highlighted that it began the year with strong progress, driven by growing contributions from its recently commercialized medicines and vaccines, along with ongoing advancements in its pipeline. It is focused and determined to fully capitalize on near-term opportunities while swiftly advancing the next wave of innovations that will improve patient outcomes and create long-term value for all stakeholders. Merck & Co., Inc. (NYSE:MRK) is also popular because of its dividend growth history, which spans 16 consecutive years. Currently, the company offers a quarterly dividend of $0.81 per share and has a dividend yield of 3.82%, as of July 26. While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Yahoo
29 minutes ago
- Yahoo
Marcus Rashford Exit Allows Man Utd to Pursue Newcastle Target Amid PSG Doubt
During his loan at Juventus, Randal Kolo Muani made a strong impact, contributing to 10 goals in 19 appearances across all competitions. However, with no agreement yet between Juventus and PSG, his future remains uncertain — leaving the door open for Premier League clubs to show interest. PSG hope his solid run in Turin will help raise his market value ahead of the summer transfer window. The club aims to recover at least half of the €95 million they spent to sign him from Eintracht Frankfurt in 2023. Playing time was limited under Luis Enrique at PSG, where Kolo Muani started just twice all season. His next step could depend on how he fits into Juventus' plans under new head coach Igor Tudor, who replaced Thiago Motta and gradually gave him more opportunities. He earned regular minutes toward the end of the 2024-25 campaign, so now the question is — where will he be next season? Could PSG outcast be headed to Old Trafford?ESPN reported on Friday that Marcus Rashford's departure has opened up some financial flexibility for Manchester United, and Kolo Muani is reportedly on the club's shortlist. Kolo Muani has made it clear he does not want to stay at PSG and has been offered to several teams, including Newcastle and Manchester United, both of which are in need of a striker. PSG is willing to accept a loan deal that includes a mandatory purchase option set at €50 million. Meanwhile, Juventus, where Kolo Muani spent the second half of last season on loan, faces financial challenges that make signing him permanently difficult.
Yahoo
an hour ago
- Yahoo
Car dealers halt sales of two second-hand models amid 'stop-drive' warning
Car dealers have been told to halt sales of second-hand Citroens amid replacements to potentially dangerous airbags. The warning was extended after the French manufacturer's parent company Stellantis issued a 'stop-drive' notice to certain Citroen models in June. It comes after a woman sustained fatal injuries caused by an airbag in a 2014 Citroen C3 in Reims, France, last year. Now, second-hand Citroens are also being included in the warning amid thousands still being listed for sale across the UK, according to This is Money. 'Buyers could have been driving away in potentially dangerous motors while also invalidating their insurance,' an article states. Since then, a team of motor trade lawyers have now issued a nationwide warning to used car dealers to suspend sales of vehicles in stock What Citroens are being recalled? The vehicles affected are second-generation Citroen C3s produced from 2009 to 2016 and first-generation DS3s manufactured from 2016 to 2019. As a result, around 82,000 C3 and DS3 models have been removed from the road across France. What is the recall on the Citroen C3 2025? The vehicles use Takata airbag systems, which could be faulty. However, Stellantis UK said that there were no reported incidents of faults in the UK, but it has decided to take action regardless. The car manufacturer in a recent statement said: 'Stellantis UK is mobilising its full network of suppliers, retailers and manufacturing plant to support this action to ensure the fastest, safest and most convenient solution for each customer. 'Stellantis remains fully committed to acting swiftly, transparently, and responsibly in addressing this issue.' Owners have been told to book their vehicles in to be rectified as early as possible and to not drive them in the meantime. However, a study by Which? revealed that hundreds of these cars were listed for sale on major used vehicle websites with no information that the manufacturer had issued a stop-drive notice. How do I check my Citroen recall? If you already own an affected Citroen, you should be contacted by letter, or you can check whether your car is affected by using the VIN check tool on Citroen's website. Recommended Reading: Citroen C3 drivers told 'stop driving' due to airbag fault How you could get a roadside fine amid new DVSA changes DVLA issues warning to anyone who passed their driving test before 2015 You will need the vehicle identification number (VIN). You can find this: at point 1 on your MOT certificate in part 4 (vehicle details) at point E in the vehicle's log book (V5C) A spokesperson from Stellantis said that they were 'working to maximise' the number of vehicles it can repair each day, with priority given to those with urgent needs.